FDA Device Intelligence
Home › Integra Lifesciences Corporation › DuraGen XS™ Dural Regeneration Matrix

DuraGen XS™ Dural Regeneration Matrix

Integra Lifesciences Corporation · Model DXM1033 · UDI-DI 10381780070979

GXQ Prescription
1
510(k) clearances
1,404
Adverse events (36 deaths)
23
Recalls
41
Facilities

Description

DuraGenXS Matrix Dural Regeneration Matrix is an absorbable implant for repair of dural defects. DuraGenXS Matrix is an easy to handle, soft, white, pliable, nonfriable, porous collagen matrix. DuraGenXS Matrix is supplied sterile, nonpyrogenic, for single use in double peel packages in a variety of sizes.

Recalls

DateFirmReason
2024-11-22Cook Biotech, Inc.Incorrect version of IFU was used rather than updated version; and incorrect expiration date was used on two of the products.
2024-09-26Integra LifeSciences Corp.Out of specification endotoxin levels.
2023-06-13Medtronic NeurosurgeryDura regeneration matrix may have out-of-specification endotoxin levels due to issues with in-process and finished goods endotoxin testing, which may present clinically with signs
2021-12-13Collagen Matrix, Inc.Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
2021-12-13Collagen Matrix, Inc.Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.